Annalise.ai has secured regulatory clearance in Europe and Singapore for its Annalise Enterprise CTB and Annalise Enterprise CXR AI software.
Annalise Enterprise CTB is designed to detect up to 130 radiological findings on noncontrast CT brain studies, including a wide range of conditions that require rapid intervention, according to the company; Annalise Enterprise CXR detects up to 124 findings on chest x-rays in under 20 seconds.
The AI software programs are now CE marked and additionally received approved for clinical use in Singapore.
